Afruja Ahad

5PUBLICATIONS
8CO-AUTHORS
Gene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Main group metal chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 19, 2025
Correction to: "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy Against Human Epidermal Growth Factor Receptor 2‑Positive Breast Cancer Mouse Model".

Afruja Ahad, Hiwa K Saeed, Virginia Del Solar

|May 16, 2024
Insights into Mechanisms and Promising Triple Negative Breast Cancer Therapeutic Potential for a Water-Soluble Ruthenium Compound.

Nazia Nayeem, Sami Sauma, Afruja Ahad

|Jan 17, 2024
Correction to "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model".

Afruja Ahad, Hiwa K Saeed, Virginia Del Solar

|Dec 14, 2023
Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model.

Afruja Ahad, Hiwa K Saeed, Virginia Del Solar

|Jul 28, 2023
Platinum(IV)-Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple-Negative Breast Cancer Models.

Javier E López-Hernández, Nazia Nayeem, José P Cerón-Carrasco

Pageof 1

Frequent Collaborators

5 joint publications

Maria Contel

3 joint publications

Hiwa K Saeed

3 joint publications

Jason S Lewis

1 joint publications

Javier E López-Hernández